Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data
View abstract on PubMed
Summary
This summary is machine-generated.Fatty liver (steatosis) is independently linked to liver fibrosis in chronic hepatitis C (CHC) patients. Controlling metabolic factors like obesity is crucial for managing CHC and preventing fibrosis progression.
Area Of Science
- Hepatology
- Viral Hepatitis Research
- Fibrosis Research
Background
- Steatosis is common in chronic hepatitis C (CHC) but its independent role in predicting liver fibrosis is unclear.
- Understanding the relationship between steatosis and fibrosis is crucial for CHC management.
- Correlates of steatosis and fibrosis in CHC require further investigation.
Purpose Of The Study
- To evaluate the association between steatosis and liver fibrosis in CHC patients.
- To identify common factors associated with both steatosis and fibrosis.
- To perform subgroup analyses based on hepatitis C virus (HCV) genotype and body mass index (BMI).
Main Methods
- A meta-analysis of individual patient data was conducted.
- Data from 3068 patients with histologically confirmed CHC were pooled from 10 international clinical centers.
- Statistical analysis included stepwise logistic regression to identify independent predictors.
Main Results
- Steatosis was present in 50.9% of patients, and fibrosis in 87.6%.
- Steatosis was independently associated with genotype 3, fibrosis, diabetes, hepatic inflammation, alcohol abuse, higher BMI, and older age.
- Fibrosis was independently associated with inflammation, steatosis, male sex, and older age; HCV genotype 2 showed reduced fibrosis.
Conclusions
- Steatosis is significantly and independently associated with liver fibrosis in CHC patients.
- Hepatic inflammation may mediate fibrogenesis in patients with liver steatosis.
- Management of CHC should focus on controlling metabolic factors like overweight through lifestyle adjustments.